Galantamine-induced Amyloid-β Clearance Mediated via Stimulation of Microglial Nicotinic Acetylcholine Receptors

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

TGF-β SIGNAL TRANSDUCTION

Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,571 · see citing works

Rho GTPases and the Actin Cytoskeleton

Hall, A. (1998) · Science · doi:10.1126/science.279.5350.509 · Cited by 6,138 · see citing works

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · see citing works

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627 · see citing works

SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE

DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565 · see citing works

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160 · see citing works

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,050 · see citing works

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012 · see citing works

Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides

Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975 · see citing works

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736 · see citing works

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP

Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611 · see citing works

Translating cell biology into therapeutic advances in Alzheimer's disease

Selkoe, D. J. (1999) · Nature · doi:10.1038/399a023 · Cited by 1,588 · see citing works

Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase

Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575 · see citing works

Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils

Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526 · see citing works

Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C. A., Hardy, J., Duff, K., Jantzen, P. T., DiCarlo, G., Wilcock, D. M., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,488 · see citing works

Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431 · see citing works

Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

Holmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R. W., Bullock, R., Love, S., Neal, J. W., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61075-2 · Cited by 1,416 · see citing works

Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397 · see citing works

APRIORITY

Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290 · see citing works

Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease

Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M. L., & Neve, R. L. (1989) · Science · doi:10.1126/science.2474201 · Cited by 907 · see citing works

Untitled work

Raskind (2000) · doi:10.1212/wnl.54.12.2261 · Cited by 870 · see citing works

WAVE, a novel WASP‐family protein involved in actin reorganization induced by Rac

Miki, H., Suetsugu, S., & Takenawa, T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.23.6932 · Cited by 709 · see citing works

Cholinergic modulation of microglial activation by α7 nicotinic receptors

Shytle, R. D., Mori, T., Townsend, K. P., Vendrame, M., Sun, N., Zeng, J., Ehrhart, J. C., Silver, A. A., Sanberg, P. R., & Tan, J. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2004.02347.x · Cited by 537 · see citing works

Untitled work

Selkoe (1999) · doi:10.1038/19866 · Cited by 468 · see citing works

Choline is a Selective Agonist of α7 Nicotinic Acetylcholine Receptors in the Rat Brain Neurons

Alkondon, M., Pereira, E. F. R., Cartes, W. S., Maelicke, A., & Albuquerque, E. X. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01702.x · Cited by 441 · see citing works

α7 Nicotinic Receptor Transduces Signals to Phosphatidylinositol 3-Kinase to Block A β-Amyloid-induced Neurotoxicity*

Kihara, T., Shimohama, S., Sawada, H., Honda, K., Nakamizo, T., Shibasaki, H., Kume, T., & Akaike, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008035200 · Cited by 393 · see citing works

Galantamine Is an Allosterically Potentiating Ligand of Neuronal Nicotinic but Not of Muscarinic Acetylcholine Receptors

Samochocki, M., Höffle‐Maas, A., Fehrenbacher, A., Jostock, R., Ludwig, J., Christner, C., Radina, M., Zerlin, M., Ullmer, C., Pereira, E. F. R., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045773 · Cited by 345 · see citing works

Microglial activation and amyloid‐β clearance induced by exogenous heat‐shock proteins

Kakimura, J., Kitamura, Y., Takata, K., Umeki, M., Suzuki, S., Shibagaki, K., Taniguchi, T., Nomura, Y., Gebicke‐Haerter, P. J., Smith, M. A., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0530fje · Cited by 331 · see citing works

The role of CaMKII as an F-actin-bundling protein crucial for maintenance of dendritic spine structure

Okamoto, K.-I., Narayanan, R., Lee, S. H., Murata, K., & Hayashi, Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701656104 · Cited by 328 · see citing works

Allosteric Sensitization of Nicotinic Receptors by Galantamine, a New Treatment Strategy for Alzheimer’s Disease

Maelicke, A., Samochocki, M., Jostock, R., Fehrenbacher, A., Ludwig, J., Albuquerque, E. X., & Zerlin, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01109-4 · Cited by 303 · see citing works

Nicotinic receptor function: new perspectives from knockout mice

Cordero‐Erausquin, M., Marubio, L. M., Klink, R., & Changeux, J. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01489-9 · Cited by 295 · see citing works

An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the α7 subtype

Papke, R. L., Bencherif, M., & Lippiello, P. M. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12889-5 · Cited by 275 · see citing works

Microglial α7 nicotinic acetylcholine receptors drive a phospholipase C/IP 3 pathway and modulate the cell activation toward a neuroprotective role

Suzuki, T., Hide, I., Matsubara, A., Hama, C., Harada, K., Miyano, K., Andrä, M., Matsubayashi, H., Sakai, N., Kohsaka, S., et al. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20850 · Cited by 241 · see citing works

Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands.

Schrattenholz, A. S., Pereira, E. F. R., Roth, U., Weber, K. H., Albuquerque, E. X., & Maelicke, A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08675-4 · Cited by 226 · see citing works

Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease

Maelicke, A., & Albuquerque, E. X. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00093-5 · Cited by 222 · see citing works

Chronic nicotine treatment reduces β‐amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw)

Nordberg, A. K., Hellström‐Lindahl, E., Lee, M., Johnson, M. A., Mousavi, M. T., Hall, R., Perry, E. K., Bednar, I., & COURT, J. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00874.x · Cited by 204 · see citing works

Amyloid-β Peptide Remnants in AN-1792-Immunized Alzheimer's Disease Patients

Patton, R., Kalback, W. M., Esh, C. L., Kokjohn, T. A., Vickle, G. D. V., Luehrs, D. C., Kuo, Y., Lopez, J. C., Brune, D. C., Ferrer, I., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060269 · Cited by 192 · see citing works

The Cognitive Benefits of Galantamine Are Sustained for at Least 36 Months: A Long-term Extension Trial

Raskind, M. A., Peskind, E. R., Truyen, L., Kershaw, P., & Damaraju, C. V. (2004) · Archives of Neurology · doi:10.1001/archneur.61.2.252 · Cited by 167 · see citing works

ALZHEIMER'S DISEASE AND RELATED DISORDERS

Raskind, M. A., & Peskind, E. R. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70341-2 · Cited by 161 · see citing works

Amyloid-β immunisation for Alzheimer's disease

Wisniewski, T., & Konietzko, U. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70170-4 · Cited by 155 · see citing works

IL-4-Induced Selective Clearance of Oligomeric β-Amyloid Peptide1–42 by Rat Primary Type 2 Microglia

Shimizu, E., Kawahara, K., Kajizono, M., Sawada, M., & Nakayama, H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6503 · Cited by 143 · see citing works

Androgens modulate β‐amyloid levels in male rat brain

Ramsden, M., Nyborg, A. C., Murphy, M. P., Chang, L. J., Stanczyk, F. Z., Golde, T. E., & Pike, C. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02114.x · Cited by 135 · see citing works

Nicotine reduces Aβ in the brain and cerebral vessels of APPsw mice

Hellström‐Lindahl, E., COURT, J. A., Keverne, J., Svedberg, M. M., Lee, M., Marutle, A., Thomas, A. J., Perry, E. K., Bednar, I., & Nordberg, A. K. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03377.x · Cited by 127 · see citing works

Galantamine modulates nicotinic receptor and blocks Aβ-enhanced glutamate toxicity

Kihara, T., Sawada, H., Nakamizo, T., Kanki, R., Yamashita, H., Maelicke, A., & Shimohama, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.132 · Cited by 124 · see citing works

Agonist and toxin sensitivities of ACh-evoked currents on neurons expressing multiple nicotinic ACh receptor subunits

Mandelzys, A., Koninck, P. D., & Cooper, E. A. (1995) · Journal of Neurophysiology · doi:10.1152/jn.1995.74.3.1212 · Cited by 95 · see citing works

High mobility group box protein‐1 inhibits microglial Aβ clearance and enhances Aβ neurotoxicity

Takata, K., Kitamura, Y., Tsuchiya, D., Kawasaki, T., Taniguchi, T., & Shimohama, S. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20340 · Cited by 81 · see citing works

Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine

Schrattenholz, A. S., Godovac‐Zimmermann, J., Schäfer, H., Albuquerque, E. X., & Maelicke, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18187.x · Cited by 80 · see citing works

Effect of Subchronic Treatment of Memantine, Galantamine, and Nicotine in the Brain of Tg2576 (APPswe) Transgenic Mice

Lithner, C. U., Svedberg, M. M., Yu, W., Hedberg, M. M., & Nordberg, A. K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098566 · Cited by 59 · see citing works

Monoclonal antibodies FK1 and WF6 define two neighboring ligand binding sites on Torpedo acetylcholine receptor alpha-polypeptide.

Schröder, B., Reinhardt-Maelicke, S., Schrattenholz, A. S., McLane, K. E., Kretschmer, A., Conti-Tronconi, B. M., & Maelicke, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34075-9 · Cited by 56 · see citing works

Involvement of Wiskott-Aldrich Syndrome Protein Family Verprolin-Homologous Protein (WAVE) and Rac1 in the Phagocytosis of Amyloid-β(1 – 42) in Rat Microglia

Kitamura, Y., Shibagaki, K., Takata, K., Tsuchiya, D., Taniguchi, T., Gebicke-Haerter, P. J., Miki, H., Takenawa, T., & Shimohama, S. (2003) · Journal of Pharmacological Sciences · doi:10.1254/jphs.92.115 · Cited by 39 · see citing works

Introductory Lecture: Allosteric Modulation of Torpedo Nicotinic Acetylcholine Receptor Ion Channel Activity by Noncompetitive Agonists

Maelicke, A., Coban, T., Storch, A., Schrattenholz, A. S., Pereira, E. F. R., & Albuquerque, E. X. (1997) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899709036592 · Cited by 39 · see citing works

Involvement of WAVE Accumulation in Aβ/APP Pathology-Dependent Tangle Modification in Alzheimer’s Disease

Takata, K., Kitamura, Y., Nakata, Y., Matsuoka, Y., Tomimoto, H., Taniguchi, T., & Shimohama, S. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080908 · Cited by 36 · see citing works

Choline availability and acetylcholine synthesis in the hippocampus of acetylcholinesterase-deficient mice

Hartmann, J., Kiewert, C., Duysen, E. G., Lockridge, O., & Klein, J. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.10.008 · Cited by 33 · see citing works

Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model

Yanagida, T., Takeuchi, H., Kitamura, Y., Takata, K., Minamino, H., Shibaike, T., Tsushima, J., Kishimoto, K., Yasui, H., Taniguchi, T., et al. (2008) · Neuroscience Research · doi:10.1016/j.neures.2008.09.003 · Cited by 31 · see citing works

Deglycosylated anti‐amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration

Takata, K., Hirata‐Fukae, C., Becker, A. G., Chishiro, S., Gray, A. J., Nishitomi, K., Franz, A. H., Sakaguchi, G., Kato, A., Mattson, M. P., et al. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05852.x · Cited by 29 · see citing works

Regulation of platelet Rac1 and Cdc42 activation through interaction with calmodulin

Elsaraj, S. M., & Bhullar, R. P. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.022 · Cited by 27 · see citing works

Update on Alzheimer Drugs (Galantamine)

Raskind, M. A. (2003) · The Neurologist · doi:10.1097/01.nrl.0000087722.46430.c4 · Cited by 26 · see citing works

Expression of two neuronal nicotinic receptor subunits in innervated and denervated adult rat muscle

Sala, C., Kimura, I., Santoro, G., Kimura, M., & Fumagalli, G. F. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12923-2 · Cited by 21 · see citing works

Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes

Kwon, H. S., & Koh, S.-H. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00221-2 · Cited by 2,595 · see citing works

Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190 · see citing works

Innate immunity in Alzheimer's disease

Heneka, M. T., Golenbock, D. T., & Latz, E. (2015) · Nature Immunology · doi:10.1038/ni.3102 · Cited by 902 · see citing works

The Gut Microbiota and Alzheimer’s Disease

Jiang, C., Li, G., Huang, P., Liu, Z., & Zhao, B. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161141 · Cited by 852 · see citing works

Bioinorganic Chemistry of Alzheimer’s Disease

Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672 · see citing works

A comparative review of cell culture systems for the study of microglial biology in Alzheimer’s disease

Stansley, B., Post, J., & Hensley, K. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-115 · Cited by 419 · see citing works

Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease

Parsons, C. G., Danysz, W., Dekundy, A., & Pulte, I. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9398-z · Cited by 337 · see citing works

Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection

Egea, J., Buendía, I., Parada, E., Navarro, E., Leon, R. M., & López, M. G. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.032 · Cited by 299 · see citing works

The biological pathways of Alzheimer disease: a review

Calabrò, M., Rinaldi, C., Santoro, G., & Crisafulli, C. (2020) · AIMS neuroscience · doi:10.3934/neuroscience.2021005 · Cited by 271 · see citing works

Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity

Pohanka, M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069809 · Cited by 248 · see citing works

Alzheimer’s disease as an inflammatory disease

Bolós, M., Perea, J. R., & Avila, J. (2017) · BioMolecular Concepts · doi:10.1515/bmc-2016-0029 · Cited by 216 · see citing works

Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease

Parri, H. R., Hernandez, C. M., & Dineley, K. T. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.039 · Cited by 199 · see citing works

Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer’s disease: Rational insights for the therapeutic approaches

Ahmad, M. H., Fatima, M., & Mondal, A. C. (2018) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2018.10.034 · Cited by 193 · see citing works

Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity

Halder, N., & Lal, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660342 · Cited by 186 · see citing works

Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders

Kalkman, H. O., & Feuerbach, D. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2175-4 · Cited by 182 · see citing works

Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice

Jiang, Y., Li, K., Li, X., Xu, L., & Yang, Z. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109452 · Cited by 154 · see citing works

Galantamine Slows Down Plaque Formation and Behavioral Decline in the 5XFAD Mouse Model of Alzheimer’s Disease

Bhattacharya, S., Haertel, C., Maelicke, A., & Montag, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089454 · Cited by 142 · see citing works

Galantamine-loaded solid–lipid nanoparticles for enhanced brain delivery: preparation, characterization, <i>in vitro</i> and <i>in vivo</i> evaluations

Misra, S., Chopra, K., Sinha, V. R., & Medhi, B. (2016) · Drug Delivery · doi:10.3109/10717544.2015.1089956 · Cited by 136 · see citing works

β-Amyloid and the Pathomechanisms of Alzheimer’s Disease: A Comprehensive View

Penke, B., Bogár, F., & Fülöp, L. (2017) · Molecules · doi:10.3390/molecules22101692 · Cited by 135 · see citing works

Cholinergic Modulation of Glial Function During Aging and Chronic Neuroinflammation

Gamage, R. V., Wagnon, I. M., Rossetti, I., Childs, R., Niedermayer, G., Chesworth, R., & Gyengési, E. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.577912 · Cited by 133 · see citing works

Neuroprotective Effects of Cholinesterase Inhibitors: Current Scenario in Therapies for Alzheimer’s Disease and Future Perspectives

Moreira, N. C. D. S., Lima, J. E. B. D. F., Marchiori, M. F., Carvalho, I., & Sakamoto‐Hojo, E. T. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210061 · Cited by 132 · see citing works

Stimulating Nicotinic Receptors Trigger Multiple Pathways Attenuating Cytotoxicity in Models of Alzheimer's and Parkinson's Diseases

Kawamata, J., & Shimohama, S. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110173 · Cited by 111 · see citing works

Acetylcholinesterase inhibitors targeting the cholinergic anti-inflammatory pathway: a new therapeutic perspective in aging-related disorders

Benfante, R., Lascio, S. D., Cardani, S., & Fornasari, D. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01359-4 · Cited by 100 · see citing works

Microglial Function in the Effects of Early-Life Stress on Brain and Behavioral Development

Catale, C., Gironda, S. C., Iacono, L. L., & Carola, V. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020468 · Cited by 99 · see citing works

A novel cell line from spontaneously immortalized murine microglia

Nagamoto‐Combs, K., Kulas, J. A., & Combs, C. K. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.05.021 · Cited by 95 · see citing works

Galantamine derivatives with indole moiety: Docking, design, synthesis and acetylcholinesterase inhibitory activity

Atanasova, M., Stavrakov, G., Philipova, I., Zheleva, D., Yordanov, N., & Doytchinova, I. A. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.058 · Cited by 94 · see citing works

The cholinergic anti-inflammatory pathway: An innovative treatment strategy for neurological diseases

Han, B., Li, X., & Hao, J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.002 · Cited by 96 · see citing works

New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease

Zueva, I. V., Dias, J., Lushchekina, S. V., Semenov, V. E., Mukhamedyarov, M. A., Pashirova, T. N., Babaev, V. M., Nachon, F., Petrova, N. V., Faritovich, N. L., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.05.025 · Cited by 91 · see citing works

Positive modulators of the α7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer's disease

Echeverrı́a, V., Iarkov, A., & Aliev, G. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.002 · Cited by 91 · see citing works

Multitarget drugs of plants origin acting on Alzheimer’s disease

Russo, P., Frustaci, A., Del Bufalo, A., Fini, M., & Cesario, A. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320130008 · Cited by 88 · see citing works

The role of astrocytic α7 nicotinic acetylcholine receptors in Alzheimer disease

Fontana, I. C., Kumar, A., & Nordberg, A. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00792-4 · Cited by 86 · see citing works

Galantamine anti-colitic effect: Role of alpha-7 nicotinic acetylcholine receptor in modulating Jak/STAT3, NF-κB/HMGB1/RAGE and p-AKT/Bcl-2 pathways

Wazea, S. A., Wadie, W., Bahgat, A. K., & El-Abhar, H. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-23359-6 · Cited by 79 · see citing works

Alzheimer’s disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation

Anwar, S., & Rivest, S. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1738391 · Cited by 78 · see citing works

Toward a Rational Design to Regulate β-Amyloid Fibrillation for Alzheimer’s Disease Treatment

Han, X., & He, G. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00477 · Cited by 77 · see citing works

Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond

Koola, M. M. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113409 · Cited by 76 · see citing works

Nanotechnology to improve the Alzheimer’s disease therapy with natural compounds

Ramalho, M. J., Andrade, S., Loureiro, J. A., & do Carmo Pereira, M. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-019-00694-3 · Cited by 75 · see citing works

Microglia as Dynamic and Essential Components of the Amyloid Hypothesis

Gandy, S., & Heppner, F. L. (2013) · Neuron · doi:10.1016/j.neuron.2013.05.007 · Cited by 73 · see citing works

An update on drug treatment options of Alzheimer's disease

Allgaier, M. (2014) · Frontiers in bioscience · doi:10.2741/4285 · Cited by 69 · see citing works

Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease

Baseman, A. S., Häger, K., Nye, J. S., Brashear, R. H., Han, J., Sano, M., Davis, B. M., & Richards, H. M. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s57909 · Cited by 69 · see citing works

Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease

Takata, K., Amamiya, T., Mizoguchi, H., Kawanishi, S., Kuroda, E., Kitamura, R., Ito, A., Saito, Y., Tawa, M., Nagasawa, T., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.021 · Cited by 67 · see citing works

Antioxidant Activity of Galantamine and Some of its Derivatives

Tsvetkova, D. D., Obreshkova, D. P., Zheleva‐Dimitrova, D., & Saso, L. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990148 · Cited by 65 · see citing works

Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer’s Disease Model Mouse

Shang, J., Yamashita, T., Zhai, Y., Nakano, Y., Morihara, R., Fukui, Y., Hishikawa, N., Ohta, Y., & Abe, K. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151126 · Cited by 64 · see citing works

Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer’s Disease

Xu, Y., Au, N. P. B., & Ma, C. H. E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.896852 · Cited by 63 · see citing works

Neurotoxicity evoked by organophosphates and available countermeasures

Pulkrabkova, L., Svobodová, B., Konecny, J., Kobrlová, T., Múčková, Ľ., Janousek, J., Pejchal, J., Korábečný, J., & Soukup, O. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03397-w · Cited by 63 · see citing works

Nicotinic Acetylcholine Receptor Signaling in Neuroprotection

Akaike, A., Shimohama, S., & Misu, Y. (2018) · Springer eBooks · doi:10.1007/978-981-10-8488-1 · Cited by 60 · see citing works

Microglial Amyloid- β 1-40 Phagocytosis Dysfunction Is Caused by High-Mobility Group Box Protein-1: Implications for the Pathological Progression of Alzheimer’s Disease

Takata, K., Takada, T., Ito, A., Asai, M., Tawa, M., Saito, Y., Ashihara, E., Tomimoto, H., Kitamura, Y., & Shimohama, S. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/685739 · Cited by 58 · see citing works

Age-Related Decline in Brain and Hepatic Clearance of Amyloid-Beta is Rectified by the Cholinesterase Inhibitors Donepezil and Rivastigmine in Rats

Mohamed, L. A., Qosa, H., & Kaddoumi, A. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00040 · Cited by 58 · see citing works

Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug

Ali, M. A., El-Abhar, H. S., Kamel, M. A. E.-N., & Attia, A. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134648 · Cited by 56 · see citing works

Astrocytic and microglial nicotinic acetylcholine receptors: an overlooked issue in Alzheimer’s disease

Sadigh‐Eteghad, S., Majdi, A., Mahmoudi, J., Golzari, S. E., & Talebi, M. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1580-z · Cited by 53 · see citing works

Importance of GPCR-Mediated Microglial Activation in Alzheimer’s Disease

Haque, M. E., Kim, I., Jakaria, M., Akther, M., & Choi, D. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00258 · Cited by 55 · see citing works

Research progress on natural products from traditional Chinese medicine in treatment of Alzheimer's disease

Gao, J., Inagaki, Y., Li, X., Kokudo, N., & Tang, W. (2013) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2013.v7.2.46 · Cited by 52 · see citing works

Formulation and Evaluation of Galantamine Gel as Drug Reservoir in Transdermal Patch Delivery System

Woo, F.-Y., Basri, M., Ahmad, M. B., & Ismail, M. (2015) · The Scientific World JOURNAL · doi:10.1155/2015/495271 · Cited by 51 · see citing works

Transplantation of Mesenchymal Stem Cells Improves Amyloid-β Pathology by Modifying Microglial Function and Suppressing Oxidative Stress

Yokokawa, K., Iwahara, N., Hisahara, S., Emoto, M. C., Saito, T., Suzuki, H., Manabe, T., Matsumura, A., Matsushita, T., Suzuki, S., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190817 · Cited by 48 · see citing works

Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer’s Disease

Kawanishi, S., Takata, K., Itezono, S., Nagayama, H., Konoya, S., Chisaki, Y., Toda, Y., Nakata, S., Yano, Y., Kitamura, Y., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170994 · Cited by 47 · see citing works

Neuroinflammation Modulation via α7 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3

Mizrachi, T., Vaknin‐Dembinsky, A., Brenner, T., & Treinin, M. (2021) · Molecules · doi:10.3390/molecules26206139 · Cited by 46 · see citing works

Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors

Stavrakov, G., Philipova, I., Lukarski, A., Atanasova, M., Zheleva‐Dimitrova, D., Zhivkova, Z. D., Ivanov, S. M., Atanasova, T., Konstantinov, S., & Doytchinova, I. A. (2020) · Molecules · doi:10.3390/molecules25153341 · Cited by 44 · see citing works

Early administration of galantamine from preplaque phase suppresses oxidative stress and improves cognitive behavior in APPswe/PS1dE9 mouse model of Alzheimer's disease

Saito, T., Hisahara, S., Iwahara, N., Emoto, M. C., Yokokawa, K., Suzuki, H., Manabe, T., Matsumura, A., Suzuki, S., Matsushita, T., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.014 · Cited by 42 · see citing works

Microglial Phagocytosis—Rational but Challenging Therapeutic Target in Multiple Sclerosis

Pinto, M. V., & Fernandes, A. M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175960 · Cited by 41 · see citing works

Molecular mechanisms and therapeutic potential of lithium in Alzheimer’s disease: repurposing an old class of drugs

Shen, Y., Zhao, M., Zhao, P., Meng, L., Zhang, Y., Zhang, G., Taishi, Y., & Sun, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1408462 · Cited by 42 · see citing works

Roles of microglia in Alzheimer’s disease and impact of new findings on microglial heterogeneity as a target for therapeutic intervention

Takata, K., Ginhoux, F., & Shimohama, S. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114754 · Cited by 40 · see citing works

Primary cultures of rat cortical microglia treated with nicotine increases in the expression of excitatory amino acid transporter 1 (GLAST) via the activation of the α7 nicotinic acetylcholine receptor

Morioka, N., Tokuhara, M., Nakamura, Y., Idenoshita, Y., Harano, S., Zhang, F. F., Hisaoka‐Nakashima, K., & Nakata, Y. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.11.044 · Cited by 39 · see citing works

Nasal Application of the Galantamine Pro-drug Memogain Slows Down Plaque Deposition and Ameliorates Behavior in 5X Familial Alzheimer’s Disease Mice

Bhattacharya, S., Maelicke, A., & Montag, D. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142421 · Cited by 39 · see citing works

URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer’s disease

Kiyota, T., Machhi, J., Lu, Y., Dyavarshetty, B., Nemati, M., Zhang, G., Mosley, R. L., Gelbard, H. A., & Gendelman, H. E. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1172-y · Cited by 38 · see citing works

Plant-Derived Alkaloids

Dey, A., & Mukherjee, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809593-5.00006-9 · Cited by 39 · see citing works

Signaling of nicotinic acetylcholine receptors in mononuclear phagocytes

Richter, K., & Grau, V. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106727 · Cited by 39 · see citing works

The dialog between neurons and microglia in Alzheimer's disease: The neurotransmitters view

Stolero, N., & Frenkel, D. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15262 · Cited by 37 · see citing works

Calcium ion influx in microglial cells: Physiological and therapeutic significance

Sharma, P., & Ping, L. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23344 · Cited by 37 · see citing works

Molecular Docking Study on Galantamine Derivatives as Cholinesterase Inhibitors

Atanasova, M., Yordanov, N., Dimitrov, I., Berkov, S. H., & Doytchinova, I. A. (2015) · Molecular Informatics · doi:10.1002/minf.201400145 · Cited by 36 · see citing works

Galantamine attenuates amyloid-β deposition and astrocyte activation in APP/PS1 transgenic mice

Wu, Z., Zhao, L., Chen, X., Cheng, X., & Zhang, Y. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.10.015 · Cited by 36 · see citing works

Autism - A Neurodevelopmental Journey from Genes to Behaviour

Eapen, V. (2011) · InTech eBooks · doi:10.5772/974 · Cited by 36 · see citing works

CD14 and Toll-Like Receptor 4 Promote Fibrillar Aβ42 Uptake by Microglia Through A Clathrin-Mediated Pathway

Fujikura, M., Iwahara, N., Hisahara, S., Kawamata, J., Matsumura, A., Yokokawa, K., Saito, T., Manabe, T., Matsushita, T., Suzuki, S., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180904 · Cited by 35 · see citing works

Regulation of microglia by neuromodulators: Modulations in major and minor modes

Albertini, G., Etienne, F., & Roumier, A. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135000 · Cited by 35 · see citing works

Nicotinic acetylcholine receptors mediate donepezil‐induced oligodendrocyte differentiation

Imamura, O., Arai, M., Dateki, M., Ogata, T., Uchida, R., Tomoda, H., & Takishima, K. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13294 · Cited by 35 · see citing works

Molecular Approaches to the Treatment, Prophylaxis, and Diagnosis of Alzheimer’s Disease: Tangle Formation, Amyloid-β, and Microglia in Alzheimer’s Disease

Takata, K., & Kitamura, Y. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11r10fm · Cited by 34 · see citing works

Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice

Iwahara, N., Hisahara, S., Kawamata, J., Matsumura, A., Yokokawa, K., Saito, T., Fujikura, M., Manabe, T., Suzuki, H., Matsushita, T., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160887 · Cited by 34 · see citing works

Acceleration of NLRP3 inflammasome by chronic cerebral hypoperfusion in Alzheimer’s disease model mouse

Shang, J., Yamashita, T., Zhai, Y., Nakano, Y., Morihara, R., Li, X., Tian, F., Liu, X., Huang, Y. C., Shi, X., et al. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.06.002 · Cited by 33 · see citing works

Docking‐based design and synthesis of galantamine–camphane hybrids as inhibitors of acetylcholinesterase

Stavrakov, G., Philipova, I., Zheleva‐Dimitrova, D., Valkova, I., Salamanova, E., Konstantinov, S., & Doytchinova, I. A. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12991 · Cited by 32 · see citing works

Disease Stage-Associated Alterations in Learning and Memory through the Electroacupuncture Modulation of the Cortical Microglial M1/M2 Polarization in Mice with Alzheimer’s Disease

Li, L., Li, L., Zhang, J., Huang, S., Liu, W., Wang, Z., Liang, S., Tao, J., & Chen, L. (2020) · Neural Plasticity · doi:10.1155/2020/8836173 · Cited by 32 · see citing works

A Novel Galantamine-Curcumin Hybrid as a Potential Multi-Target Agent against Neurodegenerative Disorders

Simeonova, R., Zheleva‐Dimitrova, D., Valkova, I., Stavrakov, G., Philipova, I., Atanasova, M., & Doytchinova, I. A. (2021) · Molecules · doi:10.3390/molecules26071865 · Cited by 32 · see citing works

Review of Advanced Drug Trials Focusing on the Reduction of Brain Beta-Amyloid to Prevent and Treat Dementia

Decourt, B., Noorda, K., Noorda, K. J., Shi, J., & Sabbagh, M. N. (2022) · Journal of Experimental Pharmacology · doi:10.2147/jep.s265626 · Cited by 32 · see citing works

Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer’s disease

Easton, A. E., Sankaranarayanan, S., Tanghe, A., Terwel, D., Lin, A., Hoque, N., Bourin, C., Gu, H., Ahlijanian, M. K., & Bristow, L. J. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3152-3 · Cited by 32 · see citing works

Understanding the Beneficial and Detrimental Effects of Donepezil and Rivastigmine to Improve their Therapeutic Value

Lane, R. M., & Darreh‐Shori, T. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142268 · Cited by 31 · see citing works

Galantamine tethered hydrogel as a novel therapeutic target for streptozotocin-induced Alzheimer’s disease in Wistar rats

Rajkumar, M., Sakthivel, M., Senthilkumar, K., Thangaraj, R., & Kannan, S. (2022) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2022.100100 · Cited by 29 · see citing works

Targeting α7-nAChR by galantamine mitigates reserpine-induced fibromyalgia-like symptoms in rats: Involvement of cAMP/PKA, PI3K/AKT, and M1/M2 microglia polarization

Atta, A. A., Ibrahim, W. W., Mohamed, A. F., & Abdelkader, N. F. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175810 · Cited by 29 · see citing works

Galantamine Nanoparticles Outperform Oral Galantamine in An Alzheimer’S Rat Model: Pharmacokinetics and Pharmacodynamics

El-Ganainy, S. O., Gowayed, M. A., Agami, M. A., Mohamed, P., Belal, M., Farid, R. M., & Hanafy, A. S. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0051 · Cited by 28 · see citing works

In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration

Chrysanthou, M., Estruch, I. M., Rietjens, I. M. C. M., Wichers, H. J., & Hoppenbrouwers, T. (2022) · Nutrients · doi:10.3390/nu14020363 · Cited by 29 · see citing works

Nicotinic Acetylcholine Receptors and Microglia as Therapeutic and Imaging Targets in Alzheimer’s Disease

Takata, K., Kimura, H., Yanagisawa, D., Harada, K., Nishimura, K., Kitamura, Y., Shimohama, S., & Tooyama, I. (2022) · Molecules · doi:10.3390/molecules27092780 · Cited by 29 · see citing works

The mixed-lineage kinase 3 inhibitor URMC-099 facilitates microglial amyloid-β degradation

Dong, W., Embury, C. M., Lu, Y., Whitmire, S. M., Dyavarshetty, B., Gelbard, H. A., Gendelman, H. E., & Kiyota, T. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0646-z · Cited by 28 · see citing works

Roles of Nicotinic Acetylcholine Receptors in the Pathology and Treatment of Alzheimer’s and Parkinson’s Diseases

Shimohama, S., & Kawamata, J. (2018) · Springer eBooks · doi:10.1007/978-981-10-8488-1_8 · Cited by 29 · see citing works

The endogenous α7 nicotinic acetylcholine receptor antagonist kynurenic acid modulates amyloid-β-induced inflammation in BV-2 microglial cells

Steiner, L., Gold, M., Mengel, D., Dodel, R. C., & Bach, J. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.06.032 · Cited by 27 · see citing works

Docking-based Design of Galantamine Derivatives with Dual-site Binding to Acetylcholinesterase

Stavrakov, G., Philipova, I., Zheleva‐Dimitrova, D., Atanasova, M., Konstantinov, S., & Doytchinova, I. A. (2016) · Molecular Informatics · doi:10.1002/minf.201600041 · Cited by 27 · see citing works

Diagnoses of Pathological States Based on Acetylcholinesterase and Butyrylcholinesterase

Pohanka, M. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190130161202 · Cited by 26 · see citing works

Targeted drug delivery systems to control neuroinflammation in central nervous system disorders

Mozafari, N., Ashrafi, H., & Azadi, A. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102802 · Cited by 25 · see citing works

Complexity of Sex Differences and Their Impact on Alzheimer’s Disease

Kadlecová, M., Freude, K., & Haukedal, H. (2023) · Biomedicines · doi:10.3390/biomedicines11051261 · Cited by 26 · see citing works

Mouse Bone Marrow-derived Microglia-like Cells Secrete Transforming Growth Factor-β1 and Promote Microglial Aβ Phagocytosis and Reduction of Brain Aβ

Kuroda, E., Nishimura, K., Kawanishi, S., Sueyoshi, M., Ueno, F., Toji, Y., Abo, N., Konishi, T., Harada, K., Satake, S., et al. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.05.004 · Cited by 24 · see citing works

Stimulation of α7 nicotinic acetylcholine receptor regulates glutamate transporter GLAST via basic fibroblast growth factor production in cultured cortical microglia

Morioka, N., Harano, S., Tokuhara, M., Idenoshita, Y., Zhang, F. F., Hisaoka‐Nakashima, K., & Nakata, Y. (2015) · Brain Research · doi:10.1016/j.brainres.2015.08.029 · Cited by 24 · see citing works

Notoginseng Saponin Rg1 Prevents Cognitive Impairment through Modulating APP Processing in Aβ1–42-injected Rats

Liu, S.-Z., Cheng, W., Shao, J.-W., Gu, Y.-F., Zhu, Y., Dong, Q.-J., Bai, S., Wang, P., & Li, L. (2019) · Current Medical Science · doi:10.1007/s11596-019-2019-1 · Cited by 23 · see citing works

Stimulation of toll-like receptor 4 downregulates the expression of α7 nicotinic acetylcholine receptors via histone deacetylase in rodent microglia

Nakamura, Y., Kimura, S., Takada, N., Takemura, M., Iwamoto, M., Hisaoka‐Nakashima, K., Nakata, Y., & Morioka, N. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104751 · Cited by 22 · see citing works

Trajectory of brain-derived amyloid beta in Alzheimer’s disease: where is it coming from and where is it going?

Liu, N., Haziyihan, A., Zhao, W. G., Chen, Y., & Chao, H. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00434-9 · Cited by 21 · see citing works

Donepezil suppresses intracellular Ca2+ mobilization through the PI3K pathway in rodent microglia

Haraguchi, Y., Mizoguchi, Y., Ohgidani, M., Imamura, Y., Murakawa‐Hirachi, T., Nabeta, H., Tateishi, H., Kato, T. A., & Monji, A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1033-0 · Cited by 22 · see citing works

Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease

Takata, K., Amamiya, T., Mizoguchi, H., Kawanishi, S., Kuroda, E., Kitamura, R., Ito, A., Saito, Y., Tawa, M., Nagasawa, T., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.021 · Cited by 67 · see citing works

Effects of nicotinic acetylcholine receptors on neurons, microglia, and bone marrow-derived microglia-like cells for the treatment of Alzheimer's disease.

Takata, K., Kuroda, E., Kitamura, Y., Shimohama, S., & Ashihara, E. (2019) · Proceedings for Annual Meeting of The Japanese Pharmacological Society · doi:10.1254/jpssuppl.92.0_1-p-010

Efficacy of galantamine treatment in very early stage of APPswe/PS1dE9 mice

Saito, T., Hisahara, S., Kawamata, J., Matsumura, A., Iwahara, N., Yokokawa, K., Fujikura, M., Manabe, T., Suzuki, H., Matsushita, T., et al. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.08.2188

Galantamine Inhibits Aβ1–42-Induced Neurotoxicity by Enhancing α7nAChR Expression as a Cargo Carrier for LC3 Binding and Aβ1–42 Engulfment During Autophagic Degradation

Lin, M., Chen, Y., Yang, H.-B., Lin, C., & Hung, S. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00803-7 · Cited by 26 · see citing works

Roles of Nicotinic Acetylcholine Receptors in the Pathology and Treatment of Alzheimer’s and Parkinson’s Diseases

Shimohama, S., & Kawamata, J. (2018) · Springer eBooks · doi:10.1007/978-981-10-8488-1_8 · Cited by 29 · see citing works